**Core Concept**
Pneumocystis jirovecii pneumonia (PCP) is a life-threatening infection that primarily affects immunocompromised individuals, such as those with HIV/AIDS. The treatment of PCP involves a combination of antibiotics and antifungals to combat the infection.

**Why the Correct Answer is Right**
The primary treatment for PCP is trimethoprim-sulfamethoxazole (TMP-SMX), a combination of a sulfonamide antibiotic (sulfamethoxazole) and a dihydrofolate reductase inhibitor (trimethoprim). TMP-SMX works by inhibiting the synthesis of tetrahydrofolate, an essential component for the growth and replication of Pneumocystis jirovecii. Additionally, pentamidine is another alternative treatment for PCP, particularly in patients who are intolerant to TMP-SMX. Adrenaline or steroids may also be used in severe cases.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not a commonly used treatment for PCP. However, in certain cases, patients may receive prophylactic TMP-SMX to prevent PCP recurrence.
**Option B:** This option is incorrect because it is not a standard treatment for PCP. While steroids may be used in severe cases of PCP, they are not a primary treatment.
**Option C:** This option is incorrect because it is not a treatment for PCP. However, it may be used to treat other types of pneumonia.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that PCP is a common opportunistic infection in immunocompromised patients, and prompt treatment is crucial to prevent severe respiratory complications.

**Correct Answer: D.**